FAAH Deletion Did Not Prevent Adaptation to Repeated High-Dose MAGL Inhibition in Mice
Removing FAAH enhanced some acute responses to MAGL inhibition in mice but did not prevent tolerance and dependence-related findings after repeated high-dose treatment. Acute amplification and chronic adaptation were separate results.
The design combined genetic and drug approaches
Researchers compared FAAH-deficient and wild-type mice given the MAGL inhibitor JZL184 acutely or for six days. FAAH and MAGL help break down different endogenous cannabinoids. The experiment therefore manipulated endogenous signaling indirectly rather than administering THC as the repeated treatment.
The initial enhancement did not persist as protection
Acute JZL184 enhanced a subset of cannabinoid-like responses in FAAH-deficient mice. Repeated treatment produced antinociceptive tolerance, cross-tolerance to THC, reduced agonist-stimulated CB1 signaling and rimonabant-precipitated withdrawal regardless of genotype. The knockout did not eliminate these adaptation outcomes.
The conclusion is dose- and regimen-specific
The study used a high-dose JZL184 regimen. It does not establish that every degree of MAGL inhibition produces the same adaptation or that lower-dose protocols are equivalent. Precipitated withdrawal also differs from observing untreated cessation, and genetic FAAH deletion is not identical to brief pharmacological inhibition.
The results indicate that simultaneously increasing two endogenous cannabinoid pathways can magnify initial effects without avoiding later tolerance. They do not support maximizing endocannabinoid levels as a clinical strategy. The relevant question is which intervention, dose and exposure duration produced each outcome.
Related: interpreting cannabis tolerance claims.
Research cited
Schlosburg JE; Kinsey SG; Ignatowska-Jankowska B; Ramesh D; Abdullah RA; Tao Q; Booker L; Long JZ; Selley DE; Cravatt BF; Lichtman AH. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice. The Journal of pharmacology and experimental therapeutics (2014). doi:10.1124/jpet.114.212753. Findings discussed from the study abstract.
